Steven Quayle PhD

Steven Quayle is Senior Vice President and Head of Research & Translational Medicine at Cue Biopharma, where he leads the advancement of the company’s Immuno-STAT™ platform to develop selective immune modulators for the treatment of autoimmune diseases and cancer.